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Abstract
During tissue healing, dynamic and temporal alterations occur in the structure and composition of 
the extracellular matrix (ECM) that are required for effective repair to occur. Matricellular proteins 
(MPs) are a group of diverse non-structural ECM components, which bind cell surface receptors 
mediating interactions between the cell and its microenviroment, effectively regulating adhesion, 
migration, proliferation, signaling and cell phenotype. Periostin (Postn), a pro-fibrogenic secreted 
glycoprotein, was defined as a MP based on its expression pattern and regulatory roles during 
development, healing and in disease processes. Postn consists of a typical signal sequence, an EMI 
domain responsible for binding to fibronectin, four tandem fasciclin-like domains that are 
responsible for integrin binding and a C-terminal region where multiple splice variants originate. 
This review will focus specifically on the role of Postn in wound healing and remodeling, an area 
of intense research in the last 10 years particularly related to skin healing as well as in 
myocardium post infarction. Postn interacts with cells through various integrin pairs and is an 
essential downstream effector of TGF-β superfamily signaling. As will be discussed, across 
different tissues, Postn is associated with pro-fibrogenic process, specifically, the transition of 
fibroblasts to myofibroblasts, collagen fibrillogenesis and ECM synthesis. Although the 
complexity of Postn as a modulator of cell behavior in tissue healing is only beginning to be 
elucidated, its expression is clearly a defining event in moving wound healing through the 
proliferative and remodeling phases.
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1. Introduction
Initially defined by Paul Bornstein in 1995 (Bornstein, 1995), matricellular proteins (MPs) 
are secreted non-structural extracellular matrix (ECM) molecules which exhibit diverse 
functions that exert control over development, pathology and tissue healing processes. In 
general, most MPs show restricted expression to development and re-expressed in post-natal 
tissues in pathologies or during wound healing (Hamilton, 2008). MPs are non-structural 
components of the ECM, and modify cell behavior through cell surface receptors such as 
integrins (Bornstein and Sage, 2002). Since the first definition of MPs based on Bornstein’s 
work on thrombospondin-1 (Reed, et al., 1993, Shingu and Bornstein, 1994), many 
additional molecules have been given this classification, including (Periostin) Postn in 2008 
(Norris, et al., 2008a), the N-Glycoprotein that is the focus of this review.
First cloned in 1993 and initially designated osteoblast specific factor-2 (Takeshita, et al., 
1993), Postn was renamed in 1999 by Horiuchi and colleagues based on its restricted 
expression to the periosteum and the periodontal ligament in mice (Horiuchi, et al., 1999). 
Postn undergoes alternate mRNA splicing (Conway and Molkentin, 2008), which generates 
variants with respect to the carboxyl tail domain terminus and multiple different isoforms 
have been identified in both mice and humans. Structurally, full length Postn is a 90 kDa 
protein that consists of a typical signal sequence, followed by a cysteine-rich region, an EMI 
domain (protein-protein interactions), four tandem fasciclin-like domains that are 
responsible for integrin binding and a C-terminal region (Kudo, 2011). There are 10 
potential residues on which Postn could also be phosphorylated (Annis, et al., 2015), and 
although somewhat controversial, there is also evidence that Postn could be a GLA-protein, 
containing canonical carboxylase recognition sites embedded between or within the fasciclin 
domains (Coutu, et al., 2008). Therefore, as well as exhibiting alternate splicing, Postn also 
has the potential to undergo post-translational modification, specifically the GLA-region via 
γ-carboxylation, maybe in a tissue specific manner. Recent evidence for this hypothesis 
arises from a study that shows Postn secreted from normal or fibrotic lung is not γ-
carboxylated (Annis, et al., 2015), which is in contrast to the results using bone marrow-
derived mesenchymal stromal cells where Postn is (Coutu, et al., 2008). The number of 
different Postn isoforms varies based on tissue of isolation. For example, in the human 
thyroid, 8 isoforms have been identified (Bai, et al., 2010), but in cardiac tissue, only 4 
isoforms are present (Morita and Komuro, 2016). The isoforms described thus far vary 
between 751 and 836 amino acids in length (Morra, et al., 2011). Based on the documented 
information, the possibility exists that although Postn isoforms arise from a single gene, they 
may more accurately represent a diverse family of proteins with very tissue specific 
expression profiles.
In postnatal animals, Postn is primarily associated with collagen-dense connective tissues 
(Hamilton, 2008). Unlike several of the other described MPs, Postn expression is maintained 
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in certain adult tissues including periosteum and periodontal ligament, which manifest in the 
phenotype of the knockout mouse (Rios, et al., 2005). Postn deletion results in significant 
damage to the tooth-supporting structures (Rios, et al., 2005), with removal of masticatory 
forces reducing this damage, showing the loss of periostin impairs the ability of the tissue to 
withstand mechanical loading (Rios, et al., 2008). Postn is heavily expressed in the 
periodontal ligament and periosteum in adult animals, and we have further described 
expression in the basal lamina in skin (Elliott, et al., 2012b, Jackson-Boeters, et al., 2009, 
Zhou, et al., 2010) and gingiva (Wen, et al., 2010) in postnatal tissues, although the 
significance of these findings has yet to be determined.
Much of our understanding of the role of MPs initially came from analysis of skin healing in 
knockout animals (for a comprehensive review, see (Walker, et al., 2015), but in the case of 
Postn, initial descriptors of its role in tissue healing came from the cardiac system (Conway 
and Molkentin, 2008, Dorn, 2007, Ladage, et al., 2013, Minicucci, et al., 2013, Norris, et al., 
2008a, Oka, et al., 2007, Shimazaki, et al., 2008). Postn, like most MPs, is most noticeably 
re-expressed as a result of tissue injury, temporally and spatially regulating different aspects 
of the repair process by modifying cell behavior (Walker, et al., 2015). In this review, we 
will focus on the role of Postn in the healing of skin and cardiac muscle, the two tissue 
systems where it has been most intensely investigated and its actions defined (Dorn, 2007, 
Elliott, et al., 2012a). Additionally, we will discuss Postn in tissues where it is known to play 
prominent roles in development and disease, and although described, its role in repair is not 
well defined.
2. Skin healing
Postn is prominently expressed during skin development in the dermis, basement membrane 
and hair follicles from embryonic through neonatal stages and in the basement membrane 
and hair follicle only in adult (Zhou, et al., 2010). The role of Postn in skin pathologies 
(Arima, et al., 2015, Crawford, et al., 2015, Mineshige, et al., 2015, Shiraishi, et al., 2012, 
Song and Qin, 2008, Supp, et al., 2012, Yamaguchi, et al., 2013, Zhang, et al., 2015, Zhou, 
et al., 2010) and wound healing (Elliott, et al., 2012a, Elliott, et al., 2012b, Jackson-Boeters, 
et al., 2009, Nishiyama, et al., 2011, Ontsuka, et al., 2012, Walker, et al., 2015, Zhou, et al., 
2010) has been the subject of intense research, which has pointed to very specific roles for 
Postn.
Skin wounds heal in a relatively rapid manner depending on their initial size. In mice, 
termination of bleeding (hemostasis) is followed by the well described temporal phases of 
inflammation, proliferation and remodeling (Walker, et al., 2015). As a result of hemostasis, 
a provisional matrix of fibrin and fibronectin forms, which temporally matures into 
granulation tissue (Greiling and Clark, 1997). Transforming growth factor-β1 (TGF-β1) is 
secreted by macrophages (Assoian, et al., 1987) and chemotactically initiates fibroblast 
migration into the loose granulation tissue matrix. We first published the expression pattern 
of Postn in full thickness excisional wound healing in 2009 (Jackson-Boeters, et al., 2009), 
demonstrating that Postn is first detected in maturing granulation tissue at day 3 post-
wounding, peaking at day 7, that latter correlating with the peak of myofibroblast presence 
during healing. Although Postn has been implicated in the regulation of inflammation in 
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certain pathological situations (Bentley, et al., 2014, Huang, et al., 2015, Izuhara, et al., 
2014, Koh, et al., 2016, Mael-Ainin, et al., 2014, Nair and Kraft, 2012, Schwanekamp, et al., 
2016), its upregulation at day 3 post wounding suggested that it plays no significant role in 
regulating inflammatory processes during acute skin healing. Moreover, we found an inverse 
correlation between inflammatory cell infiltration (CD68+ macrophages) and Postn 
expression, suggesting that Postn is not associated with the inflammatory phase of healing in 
acute wounds (Jackson-Boeters, et al., 2009).
In subsequent years, our group and that led by Professor Akira Kudo at the Tokyo Institute 
of Technology, independently performed analysis of excisional skin healing processes in 
Postn knockout (Postn−/−) mice in comparison to wild-types (Postn+/+). Representing two 
different Postn−/− mouse alleles, the studies both reported very similar delays in closure 
kinetics in the Postn−/− mice. Reduced closure was evident in Postn−/− mice from day 3 to 
day 9 post wounding, which corresponds temporally with transition from the inflammatory 
phase (day 3) into the proliferative phase of healing (days 4–9) (Elliott, et al., 2012b, 
Nishiyama, et al., 2011). Both studies similarly demonstrated that the peak of Postn mRNA 
was at 7 days post wounding (Figure 1), before declining back to baseline levels. As will be 
described below, despite these similarities, the papers identified two different mechanisms 
underlying the closure defect in Postn−/− mice.
In mice, wound closure occurs as a result of re-epithelialization and contraction. Nishimyura 
and colleagues focused on re-epithelialization of the wounds, identifying that the percent 
closure of the wounds was significantly reduced in the Postn−/− mice in comparison with 
their Postn+/+ counterparts at day 3 and 5 post-wounding (Nishiyama, et al., 2011). This 
defect in re-epithelialization was attributed to a reduction in proliferation of keratinocytes 
surrounding the hair follicles in Postn−/− mice. In vitro analysis of the role of Postn in 
proliferation using the human keratinocyte cell line HaCaT transfected either with or without 
a mouse Postn-HA overexpression vector demonstrated that Postn induced cell proliferation, 
but not migration in scratch wound assays (Nishiyama, et al., 2011). Thus the presence of 
Postn in the extracellular matrix appears to be important for stimulating keratinocyte 
proliferation, possibly through the association of Postn with laminin γ2, fibronectin, and 
bone morphogenetic protein-1.
In contrast to Nishiyama and colleagues, in our analysis of the Postn−/− mouse, we initially 
observed a reduction in wound contraction based on wound shape (also noted in (Nishiyama, 
et al., 2011) in the Postn−/− mice versus Postn+/+ mice). We therefore focused on cellular 
processes related to mesenchymal cell recruitment into the granulation tissue and transition 
of these cells to α-smooth muscle actin expressing myofibroblasts which facilitate ECM 
contraction. As fibroblasts migrate into the wound bed on the developing ECM in the 
granulation tissue, they undergo a phenotypic change triggered by TGF-β1, becoming α-
smooth muscle actin-expressing myofibroblasts (Hinz and Gabbiani, 2003). In the Postn−/− 
mouse at day 7 post-wounding, a significant reduction in myofibroblasts in the granulation 
tissue was observed, which we subsequently showed could not be attributed to a lack of 
mesenchymal cell infiltration of the wound bed, nor any changes in canonical TGF-β 
signaling. TGF-β1 signaling is classically linked to Smad2 and Smad3, which are activated 
in response to ligand binding to the TGF-β type I and II receptors (Attisano and Wrana, 
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2002), but in recent years it has been shown that FAK/TAK/JNK pathways are required for 
myofibroblast induction by TGF-β 1 (Zhang, 2009). Using Postn−/− and Postn+/+ dermal 
fibroblasts in vitro, we noted that when cultured on tissue culture plastic, cells from both 
WT and KO animals assumed a myofibroblast phenotype. Only when cells were cultured in 
collagen gels did the non-contractile phenotype of the Postn−/− fibroblasts manifest. 
Addition of recombinant Postn to the collagen gels was sufficient to recover myofibroblast 
differentiation and gel contraction. Addition of antibodies to β1 integrins or PP2 kinase 
inhibitor to inhibit Src/FAK signaling both inhibited Postn mediated contraction, 
demonstrating that Postn induces myofibroblast differentiation through non-canonical TGF-
β signaling.
β1 integrin expression in fibroblasts is required for skin healing (Liu, et al., 2010), and mice 
containing a fibroblast-specific deletion of integrin β1 show impaired healing and a 
reduction in both myofibroblasts and granulation tissue formation. Furthermore, these mice 
are also resistant to bleomycin induced skin fibrosis (Liu, et al., 2009). Interestingly, in 
atrioventricular mesenchyme, Postn localizes with β1 integrins in regions of matrix 
compaction (Butcher, et al., 2007), suggesting further that the interaction of mesenchymal 
cells with Postn through β1 integrins is a pivotal step in contraction. Postn is known to be a 
ligand for αVβ3 and αVβ5 (Gillan, et al., 2002), but β1 integrins are more associated with 
fibrillar or supermature adhesion sites (Tomasek, et al., 2002), suggesting that the role of 
Postn in matrix contraction is localized through tensin-containing fibrillar adhesions, not 
focal adhesions.
The role of ECM stiffness in myofibroblast differentiation is well defined (for 
comprehensive review see Tomasek et al (Tomasek, et al., 2002). To further investigate the 
role of ECM compliance on the relationship between Postn and myofibroblast 
differentiation, we utilized a collagen-coated flexible polyacrylamide gels of varying 
stiffness (Young’s moduli of 4800, 19200 and 50,000 Pa). As the stiffness increased Postn−/− 
fibroblasts increasingly differentiated into myofibroblasts and at 50,000 Pa, levels were 
similar between Postn−/− and Postn+/+ dermal fibroblasts. Coating of Postn with collagen on 
4800 Pa surfaces was sufficient to induce FAK phosphorylation and induce activation of α-
SMA in Postn−/− dermal fibroblasts. Therefore, Postn facilitates myofibroblast 
differentiation and matrix contraction through integrin engagement and FAK 
phosphorylation in ECM matrices that are more compliant, which would include granulation 
tissue (Grinnell, 2003). In rigid environments such as cell culture plastic, the stiffness of the 
material is sufficient to compensate for the absence of Postn to induce myofibroblast 
differentiation. In vivo evidence from Postn−/− mice support this hypothesis (Figure 2), 
myofibroblasts were present at the wound border, which has been modeled to be an area of 
peak matrix stiffness (Murray, 2003), but not in the granulation tissue itself (Grinnell, 2003). 
This data suggests that within a single wound, it is possible that multiple mechanisms may 
give rise to the myofibroblast populations evident.
From our study and that of Nishiyama et al, (Nishiyama, et al., 2011) two mechanisms for 
Postn in skin healing were identified, wound contraction and re-epithelialization. 
Interestingly, we did not quantify any change in total epithelial migration distance between 
Postn−/− mice versus Postn+/+ mice at day 7 post-wounding (Elliott, et al., 2012b), which 
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appears to contradict the work of Nishiyama (Nishiyama, et al., 2011). However, they 
observed a significant reduction in % re-epithelialization at days 3 and 5 post-wounding in 
Postn−/− mice. Therefore, the possibility exists that the initial reduction in re-
epithelialization rates is recovered by day 7. Alternatively, as healing progresses, it is 
possible that other molecules compensate for Postn deletion. For example, Postn shares high 
homology with another member of the fasciclin I family, βig-h3, and using in situ 
hybridization, we have shown that βig-h3 is highly expressed in the migrating keratinocyte 
layer during excisional healing at comparative levels in Postn−/− and Postn+/+ mice at day 7 
(Figure 3). Whether βig-h3 is involved in re-epithelialization in skin has, however, yet to be 
determined, although βig-h3 null mice are viable (Ahlfeld, et al., 2016). It must also be 
considered that assessment of re-epithelialization in murine models is problematic; their skin 
is loose, ie, is not attached to the underlying fascia and muscle beds, and skin healing in 
mice predominantly occurs as a result of wound contraction, not re-epithelialization. Future 
studies using splinted wounds to inhibit contractions may be beneficial in clearly quantifying 
whether re-epithelialization is in fact inhibited.
Based on our in vitro analysis, we next investigated whether addition of exogenous Postn 
was sufficient to rescue the wounding phenotype in the Postn−/− mice. Using electrospinning 
techniques, collagen and Postn fibrous scaffolds were produced and placed into the animals 
at the time of wounding. Analysis of α-SMA at day 7 post-wounding demonstrated that the 
addition of the Postn containing scaffolds was both necessary and sufficient to recover 
wound contraction (Elliott, et al., 2012b). These results which have been replicated by 
Ontsuka et al, who demonstrated that by “painting” recombinant Postn protein onto the 
wounded area of Postn−/− mice every 2 days, the wound closure phenotype could be rescued 
(Ontsuka, et al., 2012).
Further evidence for the importance of Postn in skin comes from analysis of its expression 
patterns in scarring (Crawford, et al., 2015, Li, et al., 2013, Song and Qin, 2008, Zhang, et 
al., 2014, Zhou, et al., 2010) and in direct contrast, non-healing skin lesions (Elliott, et al., 
2015). Postn is overexpressed in both hypertrophic and keloid scarring (Crawford, et al., 
2015, Zhou, et al., 2010). Interestingly, we have recently shown that Postn expression is 
almost completely suppressed in the wound bed of human non-healing skin lesions, which 
correlates with a complete absence of myofibroblasts in the tissue (Elliott, et al., 2015). 
Based on the findings that exogenous Postn can rescue the wound healing process in 
Postn−/− mice, it opens the intriguing possibility of using wound dressings containing 
exogenous Postn as method for speeding and/or inducing wound closure in situations of 
impaired healing.
3. Cardiac Tissue
Early studies described Postn expression during heart development, specifically in fibrous 
regions, such as the chordae tendinae, and in areas that experience high sheer stress such as 
the developing endocardial cushions and later in the mature valves (Kern, et al., 2005, 
Kruzynska-Frejtag, et al., 2001, Norris, et al., 2007, Norris, et al., 2008b). Following 
development, Postn expression remains mostly absent in healthy heart tissue, however upon 
injury is re-expressed by cardiac fibroblasts (Oka, et al., 2007, Snider, et al., 2008, Zhao, et 
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al., 2014). The effect of this upregulation has been investigated using both gain-of-, and loss-
of-function models.
Heart function has been investigated in three independently developed Postn knockout 
mouse lines. Knockout results in ~14% perinatal lethality caused by impaired valvulogenesis 
within the heart (Rios, et al., 2005, Snider, et al., 2008). However, surviving mice are grossly 
normal although display stunted growth (Oka, et al., 2007, Rios, et al., 2005, Shimazaki, et 
al., 2008). In contrast, following cardiac insult these knockout mice display more divergent 
phenotypes compared to the wild type counterparts. After experimental induction of 
myocardial infarction, Postn−/− mice exhibited a significantly decreased survival rate 
attributed to these mice having roughly twice the incidence of cardiac rupture within the first 
8 days following the ischemic insult (Oka, et al., 2007, Shimazaki, et al., 2008). 
Biomechanical investigation demonstrated that infarcted knockout hearts required a 
significantly lower applied pressure in order to rupture compared to the wild-type 
counterparts, however this was not seen in non-infarct hearts (Shimazaki, et al., 2008). These 
results were further attributed to deficits in cardiac fibroblast infiltration into the infarcted 
area and impaired ECM deposition. Importantly, in mice that did survive beyond this initial 
8-day period, Postn−/− mice displayed reduced fibrosis and improved heart function in 
comparison with wild types (Oka, et al., 2007). Similarly, following insult by pressure 
overload, Postn−/− mice did not progress to hypertrophy and maintained function, in contrast 
to wild type mice (Oka, et al., 2007). In a comparable study investigating Dahl salt-sensitive 
rats fed a high salt diet as a model for hypertension, anti-sense oligonucleotides for Postn 
mRNA led to improved survival and heart function (Katsuragi, et al., 2004). These studies 
emphasize that while increasing Postn expression may be an adaptive response following 
acute injury to quickly regain ECM and tissue homeostasis, prolonged expression as seen 
following acute injury, or in chronic stress conditions leads to an excessive fibrotic response 
and ultimately impairs function. While there is a strong link between Postn and the fibrotic 
response in several tissues, its effect on hypertrophy appears to be context dependent. 
Whereas above, pressure overload induced hypertrophy was reduced in Postn−/− mice (Oka, 
et al., 2007), in a genetic model of hypertrophic cardiomyopathy established by mutation of 
the α-myosin heavy chain (MHC) gene, Postn−/− mice did not exhibit reduced hypertrophy, 
but lesser proliferation of non-cardiomyocyte cells and a reduction in the extent of fibrosis 
was quantified (Teekakirikul, et al., 2010). Conversely, liposomal delivery of Postn cDNA 
impaired heart function (Katsuragi, et al., 2004), in uninjured hearts.
4. Periodontium
Periodontium refers to the specialized connective tissues that anchor teeth in the jaw, 
facilitating transmission of the stresses of mastication. Structurally, it consists of the gingiva, 
periodontal ligament (PDL), cementum, and alveolar bone. Postn is expressed during tooth 
development (Ma, et al., 2011, Suzuki, et al., 2004) and expression is maintained throughout 
adulthood in the PDL. In the adult periodontium, Postn is highly expressed in the PDL and 
in periosteal and endosteal progenitor cells associated with the alveolar bone demonstrating 
that Postn plays a specific role in the periodontium (Rios, et al., 2008, Wen, et al., 2010). A 
more recent study demonstrated that Postn expression in the PDL temporarily decreases 
following the removal of the occlusal force in mice and human (Afanador, et al., 2005).
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Analysis of the Postn−/− mouse phenotype revealed significant periodontal disease-like 
characteristics, including resorption of the alveolar bone and a rapid degeneration of the 
PDL (Rios, et al., 2005, Rios, et al., 2008). In adult humans, Postn is highly expressed in the 
PDL and periosteum of alveolar bone (Wen, et al., 2010). Postn is known to organize the 
extracellular matrix at the tooth interface of the alveolar bone and PDL throughout 
adulthood (Kruzynska-Frejtag, et al., 2004), likely through its regulation of collagen 
fibrillogenesis (Choi, et al., 2011, Norris, et al., 2007) and possibly modulation of 
progenitor-cell phenotype (Coutu, et al., 2008, Kawanami, et al., 2009, Tkatchenko, et al., 
2009). Despite extensive knowledge on Postn expression in the periodontium, comparatively 
little is known about its role in healing of periodontal structures.
There are two areas that Postn has been examined in 1) periodontal surgery (Padial-Molina, 
et al., 2015) and 2) experimental tooth movement (Rangiani, et al., 2015, Wilde, et al., 
2003). Using an observational prospective case-control study Padial-Molina and colleagues 
assessed Postn expression in patients with and without periodontitis. Histologically, they 
identified that Postn protein levels were reduced in the sub-epithelial tissues in patients with 
periodontitis, which has been shown previously in a rat model to result from inflammatory 
processes (Padial-Molina, et al., 2012). Following surgery in humans however, Postn levels 
increased in gingival crevicular fluid (GCF) in both healthy and disease patients, although 
was higher in the latter group. With increasing time post-surgery, levels of Postn decline in 
the GCF in both patient groups, possibly due to its incorporation into the maturing ECM. 
This study clearly shows however, that Postn protein levels show temporal changes during 
the healing phase post surgery in human subjects.
Postn has also been investigated in experimental tooth movement, an orthodontic procedure 
that can be considered to induce damage, healing and remodeling as a result of the 
application of force to teeth, particularly in the periodontal ligament and bone where Postn is 
prominently expressed (Hamilton, 2008, Rios, et al., 2005, Rios, et al., 2008, Wen, et al., 
2010, Yamada, et al., 2014). Three phases of orthodontic tooth movement have been 
proposed. The first phase (1 to 2 days) is a tooth movement immediately after the force 
application. In the second phase (20 to 30 days), tooth movement ceases because of the 
hyalinization in the compressed zone of the PDL. The hyalinized zone of the PDL is 
necrotic, cell-free, and lacks normal tissue architecture. The last phase involves the removal 
of the necrotic tissue and at this stage, the tooth movement resumes. During experimental 
tooth movement, Postn expression has been shown to be upregulated in the compression 
sites compared to tension sites of the PDL following experimental tooth movement in mice 
(Wilde, et al., 2003). In a subsequent study by Rangiani and colleagues, they assessed 
experimental tooth movement, comparing the process directly in Postn−/− and Postn+/+ mice 
(Rangiani, et al., 2015). Interestingly, the process of tooth movement was significantly 
slower in Postn−/− mice compared to wild types, and this was concomitant with no change in 
sclerostin expression, but reduced numbers of osteoclasts and the integrity of collagen fibers 
was also significantly compromised. However, no mechanistic studies were performed, so 
whether the role of Postn is direct or indirect in these processes is yet to be determined.
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5. Tendon and Ligaments
Upon tendon injury, the inflammatory phase of tissue repair is activated during which 
inflammatory cells rid the tissue of necrotic material. Tenocytes then migrate to the wound 
where they secrete type III collagen during the first few weeks of repair, followed by type I 
collagen as the repair becomes fibrotic. This fibrous tissue eventually remodels giving a 
tendon with a scar-like composition which (Sharma and Maffulli, 2006), although repaired 
does not match the biochemical and biomechanical properties of the original undamaged 
tissue.
The first observation of Postn in the tendon came from Norris et al who reported Postn co-
localized with collagen type I in the tendons of adult mice (Norris, et al., 2007). While 
investigating the role of Postn in collagen I fibrillogenesis, they found that collagen I 
obtained from the tendons of Postn−/− mice had both reduced fibril diameters and 
denaturation temperatures, which was indicative of impaired fibril organization and 
crosslinking (Norris, et al., 2007). The finding that Postn regulates collagen I fibrillogenesis 
has important implications for the tendon, as the healthy tendon extracellular matrix consists 
largely of type I collagen (Sharma and Maffulli, 2006). Postn localization in the tendon has 
also been reported during mouse mandible development, where it was shown to have 
distribution patterns similar to TIMP-2 (Yoshiba, et al., 2007), in studies involving murine 
achilles tendons (Chamberlain, et al., 2013, Noack, et al., 2014) where it is expressed by 
both tenocytes and chrondrocytes (Noack, et al., 2014) and in the patellar tendon (Little, et 
al., 2014).
Although its role in tendon repair has not been fully elucidated, a recent surgical model of 
tendon repair demonstrated that Postn expression was upregulated at all time points 
following tendon injury, corresponding with an increase in type III collagen expression 
(Chamberlain, et al., 2011). Postn has also been found to be upregulated in human 
tendinopathy (Jelinsky, et al., 2011). Another study showed Postn upregulation in BMP2/
Smad8ca-expressing C3H10½ cells, a tenogenic model cell line that forms tendon-like 
structures both in vitro and in vivo, suggesting that its secretion contributes to tendon 
formation (Noack, et al., 2014). To confirm Postn’s role in tenogenesis, the group compared 
Postn expression between the achilles tendon and muscle of adult mice, finding not only 
higher expression in the achilles tendon relative to muscle, but also higher expression of 
Postn in the tendon relative to tendon-specific genes such as scleraxis and tenomodulin. 
Finally, when Postn was overexpressed in human MSCs in vivo, it led to the formation of 
wavy fibroblastic tendon-like tissue (Noack, et al., 2014). Taken together these studies 
suggest that Postn plays a role in both tendon formation and repair, by interacting with and 
organizing the extracellular matrix of the tendon (Chamberlain, et al., 2013, Noack, et al., 
2014).
Fewer investigations have been performed with respect to potential roles for Postn role in 
ligament repair. Postn expression has been documented in rat medial collateral ligament 
(MCL) (Chamberlain, et al., 2013), in the human anterior cruciate ligament (ACL) (Little, et 
al., 2014) and in human transverse carpel ligaments (Shih, et al., 2009). Microarray analysis 
to identify genes that contribute to the early stages of tendon repair found that Postn mRNA 
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was significantly upregulated at 7 days following bilateral transection of rat MCLs 
(Chamberlain, et al., 2013). Using immunohistochemistry, the group also detected an 
increase in Postn protein at day 3 post injury, with a further increase at day 7. Therefore, as 
is evident in skin, Postn increases in the first week of healing, where it influences fibroblast 
phenotype and regulates collagen synthesis (Chamberlain, et al., 2013).
6. Skeletal Muscle
During skeletal muscle regeneration, Postn has been found to be highly upregulated 
following cardiotoxin induced injury in both the gastrocnemius (Goetsch, et al., 2003) and 
tibialis anterior (Ozdemir, et al., 2014) muscles in mice. Although absent from healthy adult 
muscle, following injury, Postn is expressed within fibroblasts and macrophages that 
infiltrate the damaged tissue as well as within the regenerating myofibers (Goetsch, et al., 
2003, Ozdemir, et al., 2014). This expression profile has prompted others to investigate its 
expression in highly relevant muscular dystrophy models. Postn displayed upregulation in 
dystrophic gastrocnemius muscle from mdx mice (Marotta, et al., 2009), as well as in the 
diaphragm of mdx-4cv mice (Holland, et al., 2015). These data were further supported using 
the Sgcd−/− mouse model for muscular dystrophy and this expression profile correlated well 
with biopsies from patients with Duchenne muscular dystrophy (Lorts, et al., 2012). 
Interestingly, when crossed with Postn−/− mice to produce Sgcd−/− postn−/− double 
knockouts, the pathology was less severe in both the gastrocnemius and quadriceps muscles 
investigated. Importantly, these mice displayed enhanced ECM turnover, decreased fibrosis 
and enhanced myofiber regeneration. Moreover, the double knockout mice exhibited 
improved muscle function.
6. When Healing Fails to Stop: Periostin in Fibrosis
Postn has been associated with development and the severity of fibrotic conditions in 
numerous tissues (Bentley, et al., 2014, Huang, et al., 2015, Izuhara, et al., 2014, Kim, et al., 
2013, Lorts, et al., 2012, Mael-Ainin, et al., 2014, Naik, et al., 2012, Norris, et al., 2008a, 
Oka, et al., 2007, Zhou, et al., 2010) and a search for Postn and fibrosis in pubmed returns 
136 papers (out of 836 total on Postn). In many instances, fibrosis is idiopathic 
(Nanthakumar, et al., 2015), but the same cellular processes underlying fibrotic conditions 
are also required in the healing response in tissues such as skin (Elliott and Hamilton, 2011). 
In normal tissue following the proliferative/fibrotic phase of healing, myofibroblast 
populations undergo apoptosis, leaving a relatively acellular collagen-dense scar tissue, and 
it is the persistence of these myofibroblast populations that results in excessive ECM 
production/remodeling and increased tissue contraction (Hinz and Gabbiani, 2003, Tomasek, 
et al., 2002).
In healthy skin, Postn is normally expressed in the basal lamina (Zhou, et al., 2010), but it is 
overexpressed in both keloid and hypertrophic scarring post-injury (Crawford, et al., 2015, 
Song and Qin, 2008, Zhou, et al., 2010), where it increases fibroblast proliferation and 
contractility (Crawford, et al., 2015). In addition, Postn has been shown to promote 
angiogenesis in keloid scars (Zhang, et al., 2015), which is interesting as keloid scars are 
often hypoxic in nature (Ueda, et al., 2004). Consistent with these findings, Postn is 
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upregulated in keloid fibroblasts in response to hypoxia, where the presence of the protein 
mediates migration, proliferation and collagen synthesis of fibroblasts (Zhang, et al., 2014). 
Based on the studies performed to date, continued expression of Postn is associated with 
scar formation, and its inhibition may represent a legitimate target to reduce fibrosis after 
skin injury (Figure 4).
Similar to skin, in healthy human cardiac tissue, Postn mRNA is relatively low and the 
protein is not detectable by Western blotting (Zhao, et al., 2014), but in myocardial fibrosis 
(Zhao, et al., 2014) or post infarction (Minicucci, et al., 2013), Postn increases significantly, 
where it correlates with remodeling events. Interestingly, genetic deletion of Postn results in 
an increased risk of ventricular rupture, but in mice that survive, less fibrosis is evident in 
the remodeled myocardium in comparison with wild-type mice (Oka, et al., 2007). This is 
further demonstrated in a swine model, where controlled release of Postn post infarction 
improved heart function, but stimulated fibrosis (Ladage, et al., 2013). Whether Postn 
represents a target to inhibit fibrosis in the cardiac system is far from clear, as its complete 
inhibition may also prevent necessary remodeling to prevent wall thinning and rupture.
7. Concluding Remarks
Analysis of Postn in multiple wound healing models place this matricellular protein as a key 
modulator of cell phenotype and processes essential for proper wound resolution, but as 
discussed, it also is associated with fibrosis. The patterns of Postn expression are very 
similar between divergent tissues, suggesting a similar requirement temporally for the 
presence of the protein in healing. As the molecule itself becomes better defined, it will be 
of great interest to see how just how tissue specific certain isoforms are and whether post-
translational modifications further enhance the activity of the molecule. However, the 
research performed thus far place Postn as a critical regulator of cell processes underlying 
the proliferative and remodeling phases of healing.
Acknowledgments
This work was funded in part by: Canadian Institutes of Health Research (Operating grant RN247506) and the 
Canadian Foundation for Innovation Leaders Opportunity Fund (no. 18742) to D. W. Hamilton, and National 
Institutes of Health R01 HL115619 to S. J. Conway.
References
Afanador E, Yokozeki M, Oba Y, Kitase Y, Takahashi T, Kudo A, Moriyama K. Messenger RNA 
expression of periostin and Twist transiently decrease by occlusal hypofunction in mouse 
periodontal ligament. Archives of oral biology. 2005; 50:1023–1031. [PubMed: 15922993] 
Ahlfeld SK, Wang J, Gao Y, Snider P, Conway SJ. Initial Suppression of Transforming Growth Factor-
beta Signaling and Loss of TGFBI Causes Early Alveolar Structural Defects Resulting in 
Bronchopulmonary Dysplasia. The American journal of pathology. 2016
Annis DS, Ma H, Balas DM, Kumfer KT, Sandbo N, Potts GK, Coon JJ, Mosher DF. Absence of 
Vitamin K-Dependent gamma-Carboxylation in Human Periostin Extracted from Fibrotic Lung or 
Secreted from a Cell Line Engineered to Optimize gamma-Carboxylation. PloS one. 2015; 
10:e0135374. [PubMed: 26273833] 
Arima K, Ohta S, Takagi A, Shiraishi H, Masuoka M, Ontsuka K, Suto H, Suzuki S, Yamamoto K, 
Ogawa M, Simmons O, Yamaguchi Y, Toda S, Aihara M, Conway SJ, Ikeda S, Izuhara K. Periostin 
contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis. Allergology 
Walker et al. Page 11
Cell Tissue Res. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
international : official journal of the Japanese Society of Allergology. 2015; 64:41–48. [PubMed: 
25572557] 
Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. 
Expression and secretion of type beta transforming growth factor by activated human macrophages. 
Proceedings of the National Academy of Sciences of the United States of America. 1987; 84:6020–
6024. [PubMed: 2888109] 
Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002; 296:1646–
1647. [PubMed: 12040180] 
Bai Y, Nakamura M, Zhou G, Li Y, Liu Z, Ozaki T, Mori I, Kakudo K. Novel isoforms of periostin 
expressed in the human thyroid. Japanese clinical medicine. 2010; 1:13–20. [PubMed: 23946676] 
Bentley JK, Chen Q, Hong JY, Popova AP, Lei J, Moore BB, Hershenson MB. Periostin is required for 
maximal airways inflammation and hyperresponsiveness in mice. The Journal of allergy and clinical 
immunology. 2014; 134:1433–1442. [PubMed: 24996263] 
Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 
1. The Journal of cell biology. 1995; 130:503–506. [PubMed: 7542656] 
Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Current opinion 
in cell biology. 2002; 14:608–616. [PubMed: 12231357] 
Butcher JT, Norris RA, Hoffman S, Mjaatvedt CH, Markwald RR. Periostin promotes atrioventricular 
mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-
kinase. Developmental biology. 2007; 302:256–266. [PubMed: 17070513] 
Chamberlain CS, Brounts SH, Sterken DG, Rolnick KI, Baer GS, Vanderby R. Gene profiling of the 
rat medial collateral ligament during early healing using microarray analysis. J Appl Physiol 
(1985). 2011; 111:552–565. [PubMed: 21596919] 
Chamberlain CS, Duenwald-Kuehl SE, Okotie G, Brounts SH, Baer GS, Vanderby R. Temporal 
healing in rat achilles tendon: ultrasound correlations. Annals of biomedical engineering. 2013; 
41:477–487. [PubMed: 23149902] 
Choi JW, Arai C, Ishikawa M, Shimoda S, Nakamura Y. Fiber system degradation, and periostin and 
connective tissue growth factor level reduction, in the periodontal ligament of teeth in the absence 
of masticatory load. Journal of periodontal research. 2011; 46:513–521. [PubMed: 21762408] 
Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and 
disease. Current genomics. 2008; 9:548–555. [PubMed: 19516962] 
Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. Periostin, a member of a novel 
family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. The Journal 
of biological chemistry. 2008; 283:17991–18001. [PubMed: 18450759] 
Crawford J, Nygard K, Gan BS, O’Gorman DB. Periostin induces fibroblast proliferation and 
myofibroblast persistence in hypertrophic scarring. Experimental dermatology. 2015; 24:120–126. 
[PubMed: 25421393] 
Dorn GW 2nd. Periostin and myocardial repair, regeneration, and recovery. The New England journal 
of medicine. 2007; 357:1552–1554. [PubMed: 17928607] 
Elliott CG, Forbes TL, Leask A, Hamilton DW. Inflammatory microenvironment and tumor necrosis 
factor alpha as modulators of periostin and CCN2 expression in human non-healing skin wounds 
and dermal fibroblasts. Matrix biology : journal of the International Society for Matrix Biology. 
2015; 43:71–84. [PubMed: 25779637] 
Elliott CG, Hamilton DW. Deconstructing fibrosis research: do pro-fibrotic signals point the way for 
chronic dermal wound regeneration? Journal of cell communication and signaling. 2011; 5:301–
315. [PubMed: 21503732] 
Elliott CG, Kim SS, Hamilton DW. Functional significance of periostin in excisional skin repair: is the 
devil in the detail? Cell adhesion & migration. 2012a; 6:319–326. [PubMed: 22983194] 
Elliott CG, Wang J, Guo X, Xu SW, Eastwood M, Guan J, Leask A, Conway SJ, Hamilton DW. 
Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. 
Journal of cell science. 2012b; 125:121–132. [PubMed: 22266908] 
Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial 
ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell 
motility. Cancer research. 2002; 62:5358–5364. [PubMed: 12235007] 
Walker et al. Page 12
Cell Tissue Res. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Goetsch SC, Hawke TJ, Gallardo TD, Richardson JA, Garry DJ. Transcriptional profiling and 
regulation of the extracellular matrix during muscle regeneration. Physiological genomics. 2003; 
14:261–271. [PubMed: 12799472] 
Greiling D, Clark RA. Fibronectin provides a conduit for fibroblast transmigration from collagenous 
stroma into fibrin clot provisional matrix. Journal of cell science. 1997; 110(Pt 7):861–870. 
[PubMed: 9133673] 
Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends in cell biology. 2003; 
13:264–269. [PubMed: 12742170] 
Hamilton DW. Functional role of periostin in development and wound repair: implications for 
connective tissue disease. Journal of cell communication and signaling. 2008; 2:9–17. [PubMed: 
18642132] 
Hinz B, Gabbiani G. Mechanisms of force generation and transmission by myofibroblasts. Current 
opinion in biotechnology. 2003; 14:538–546. [PubMed: 14580586] 
Holland A, Dowling P, Meleady P, Henry M, Zweyer M, Mundegar RR, Swandulla D, Ohlendieck K. 
Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular 
protein periostin as a potential factor involved in dystrophinopathy-related fibrosis. Proteomics. 
2015; 15:2318–2331. [PubMed: 25737063] 
Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, 
Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression 
to periosteum and periodontal ligament and increased expression by transforming growth factor 
beta. Journal of bone and mineral research : the official journal of the American Society for Bone 
and Mineral Research. 1999; 14:1239–1249.
Huang Y, Liu W, Xiao H, Maitikabili A, Lin Q, Wu T, Huang Z, Liu F, Luo Q, Ouyang G. 
Matricellular protein periostin contributes to hepatic inflammation and fibrosis. The American 
journal of pathology. 2015; 185:786–797. [PubMed: 25541330] 
Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto K. Periostin in allergic inflammation. 
Allergology international : official journal of the Japanese Society of Allergology. 2014; 63:143–
151. [PubMed: 24662806] 
Jackson-Boeters L, Wen W, Hamilton DW. Periostin localizes to cells in normal skin, but is associated 
with the extracellular matrix during wound repair. Journal of cell communication and signaling. 
2009; 3:125–133. [PubMed: 19543815] 
Jelinsky SA, Rodeo SA, Li J, Gulotta LV, Archambault JM, Seeherman HJ. Regulation of gene 
expression in human tendinopathy. BMC musculoskeletal disorders. 2011; 12:86. [PubMed: 
21539748] 
Katsuragi N, Morishita R, Nakamura N, Ochiai T, Taniyama Y, Hasegawa Y, Kawashima K, Kaneda Y, 
Ogihara T, Sugimura K. Periostin as a novel factor responsible for ventricular dilation. Circulation. 
2004; 110:1806–1813. [PubMed: 15381649] 
Kawanami A, Matsushita T, Chan YY, Murakami S. Mice expressing GFP and CreER in osteochondro 
progenitor cells in the periosteum. Biochemical and biophysical research communications. 2009; 
386:477–482. [PubMed: 19538944] 
Kern CB, Hoffman S, Moreno R, Damon BJ, Norris RA, Krug EL, Markwald RR, Mjaatvedt CH. 
Immunolocalization of chick periostin protein in the developing heart. The anatomical record Part 
A, Discoveries in molecular, cellular, and evolutionary biology. 2005; 284:415–423.
Kim SS, Jackson-Boeters L, Darling MR, Rieder MJ, Hamilton DW. Nifedipine induces periostin 
expression in gingival fibroblasts through TGF-beta. Journal of dental research. 2013; 92:1022–
1028. [PubMed: 24004653] 
Koh SJ, Choi Y, Kim BG, Lee KL, Kim DW, Kim JH, Kim JW, Kim JS. Matricellular Protein Periostin 
Mediates Intestinal Inflammation through the Activation of Nuclear Factor kappaB Signaling. PloS 
one. 2016; 11:e0149652. [PubMed: 26890265] 
Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ. Periostin (an osteoblast-
specific factor) is expressed within the embryonic mouse heart during valve formation. 
Mechanisms of development. 2001; 103:183–188. [PubMed: 11335131] 
Kruzynska-Frejtag A, Wang J, Maeda M, Rogers R, Krug E, Hoffman S, Markwald RR, Conway SJ. 
Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal 
Walker et al. Page 13
Cell Tissue Res. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
interaction. Developmental dynamics : an official publication of the American Association of 
Anatomists. 2004; 229:857–868. [PubMed: 15042709] 
Kudo A. Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the 
cell. Cellular and molecular life sciences : CMLS. 2011; 68:3201–3207. [PubMed: 21833583] 
Ladage D, Yaniz-Galende E, Rapti K, Ishikawa K, Tilemann L, Shapiro S, Takewa Y, Muller-Ehmsen 
J, Schwarz M, Garcia MJ, Sanz J, Hajjar RJ, Kawase Y. Stimulating myocardial regeneration with 
periostin Peptide in large mammals improves function post-myocardial infarction but increases 
myocardial fibrosis. PloS one. 2013; 8:e59656. [PubMed: 23700403] 
Li BL, Hou JJ, Nie FF, Qin ZL, Zhao X, Zhang Z, Ma YG. [Variations in expressions of periostin and 
related factors in early stage of wound healing and scar remodeling in rats]. Zhonghua wei zhong 
bing ji jiu yi xue. 2013; 25:523–526. [PubMed: 24059416] 
Little D, Thompson JW, Dubois LG, Ruch DS, Moseley MA, Guilak F. Proteomic differences between 
male and female anterior cruciate ligament and patellar tendon. PloS one. 2014; 9:e96526. 
[PubMed: 24818782] 
Liu S, Kapoor M, Denton CP, Abraham DJ, Leask A. Loss of beta1 integrin in mouse fibroblasts 
results in resistance to skin scleroderma in a mouse model. Arthritis and rheumatism. 2009; 
60:2817–2821. [PubMed: 19714619] 
Liu S, Xu SW, Blumbach K, Eastwood M, Denton CP, Eckes B, Krieg T, Abraham DJ, Leask A. 
Expression of integrin beta1 by fibroblasts is required for tissue repair in vivo. Journal of cell 
science. 2010; 123:3674–3682. [PubMed: 20940256] 
Lorts A, Schwanekamp JA, Baudino TA, McNally EM, Molkentin JD. Deletion of periostin reduces 
muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta 
pathway. Proceedings of the National Academy of Sciences of the United States of America. 2012; 
109:10978–10983. [PubMed: 22711826] 
Ma D, Zhang R, Sun Y, Rios HF, Haruyama N, Han X, Kulkarni AB, Qin C, Feng JQ. A novel role of 
periostin in postnatal tooth formation and mineralization. The Journal of biological chemistry. 
2011; 286:4302–4309. [PubMed: 21131362] 
Mael-Ainin M, Abed A, Conway SJ, Dussaule JC, Chatziantoniou C. Inhibition of periostin expression 
protects against the development of renal inflammation and fibrosis. Journal of the American 
Society of Nephrology : JASN. 2014; 25:1724–1736. [PubMed: 24578131] 
Marotta M, Ruiz-Roig C, Sarria Y, Peiro JL, Nunez F, Ceron J, Munell F, Roig-Quilis M. Muscle 
genome-wide expression profiling during disease evolution in mdx mice. Physiological genomics. 
2009; 37:119–132. [PubMed: 19223608] 
Mineshige T, Kamiie J, Sugahara G, Yasuno K, Aihara N, Kawarai S, Yamagishi K, Shirota M, Shirota 
K. Expression of Periostin in Normal, Atopic, and Nonatopic Chronically Inflamed Canine Skin. 
Veterinary pathology. 2015; 52:1118–1126. [PubMed: 25755133] 
Minicucci MF, Santos PP, Rafacho BP, Goncalves AF, Ardisson LP, Batista DF, Azevedo PS, Polegato 
BF, Okoshi K, Pereira EJ, Paiva SA, Zornoff LA. Periostin as a modulator of chronic cardiac 
remodeling after myocardial infarction. Clinics (Sao Paulo). 2013; 68:1344–1349. [PubMed: 
24212842] 
Morita H, Komuro I. Periostin Isoforms and Cardiac Remodeling After Myocardial Infarction: Is the 
Dispute Settled? Hypertension. 2016; 67:504–505. [PubMed: 26831197] 
Morra L, Rechsteiner M, Casagrande S, Duc Luu V, Santimaria R, Diener PA, Sulser T, Kristiansen G, 
Schraml P, Moch H, Soltermann A. Relevance of periostin splice variants in renal cell carcinoma. 
The American journal of pathology. 2011; 179:1513–1521. [PubMed: 21763681] 
Murray, JD. Model for fibroblast-driven wound healing: residual strain and tissue remodelling. In: 
Antman, SS.Marsden, JE.Sirovich, J., Wiggins, S., editors. Mathematical Biology II: Spatial 
Models and Biomedical Applications. Vol. 2. Springer-Verlag Inc; New York: 2003. p. 503-510.
Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, Fry CD, White ES, Sisson TH, 
Tayob N, Carnemolla B, Orecchia P, Flaherty KR, Hershenson MB, Murray S, Martinez FJ, Moore 
BB. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary 
fibrosis. American journal of physiology Lung cellular and molecular physiology. 2012; 
303:L1046–1056. [PubMed: 23043074] 
Walker et al. Page 14
Cell Tissue Res. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Nair P, Kraft M. Serum periostin as a marker of T(H)2-dependent eosinophilic airway inflammation. 
The Journal of allergy and clinical immunology. 2012; 130:655–656. [PubMed: 22935590] 
Nanthakumar CB, Hatley RJ, Lemma S, Gauldie J, Marshall RP, Macdonald SJ. Dissecting fibrosis: 
therapeutic insights from the small-molecule toolbox. Nature reviews Drug discovery. 2015; 
14:693–720. [PubMed: 26338155] 
Nishiyama T, Kii I, Kashima TG, Kikuchi Y, Ohazama A, Shimazaki M, Fukayama M, Kudo A. 
Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. PloS one. 
2011; 6:e18410. [PubMed: 21490918] 
Noack S, Seiffart V, Willbold E, Laggies S, Winkel A, Shahab-Osterloh S, Florkemeier T, Hertwig F, 
Steinhoff C, Nuber UA, Gross G, Hoffmann A. Periostin secreted by mesenchymal stem cells 
supports tendon formation in an ectopic mouse model. Stem cells and development. 2014; 
23:1844–1857. [PubMed: 24809660] 
Norris RA, Borg TK, Butcher JT, Baudino TA, Banerjee I, Markwald RR. Neonatal and adult 
cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Annals 
of the New York Academy of Sciences. 2008a; 1123:30–40. [PubMed: 18375575] 
Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, Moreno-Rodriguez R, Trusk T, Potts 
JD, Goodwin RL, Davis J, Hoffman S, Wen X, Sugi Y, Kern CB, Mjaatvedt CH, Turner DK, Oka 
T, Conway SJ, Molkentin JD, Forgacs G, Markwald RR. Periostin regulates collagen 
fibrillogenesis and the biomechanical properties of connective tissues. Journal of cellular 
biochemistry. 2007; 101:695–711. [PubMed: 17226767] 
Norris RA, Moreno-Rodriguez RA, Sugi Y, Hoffman S, Amos J, Hart MM, Potts JD, Goodwin RL, 
Markwald RR. Periostin regulates atrioventricular valve maturation. Developmental biology. 
2008b; 316:200–213. [PubMed: 18313657] 
Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 
2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD. Genetic manipulation of periostin 
expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circulation research. 
2007; 101:313–321. [PubMed: 17569887] 
Ontsuka K, Kotobuki Y, Shiraishi H, Serada S, Ohta S, Tanemura A, Yang L, Fujimoto M, Arima K, 
Suzuki S, Murota H, Toda S, Kudo A, Conway SJ, Narisawa Y, Katayama I, Izuhara K, Naka T. 
Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal 
fibroblasts. Experimental dermatology. 2012; 21:331–336. [PubMed: 22509828] 
Ozdemir C, Akpulat U, Sharafi P, Yildiz Y, Onbasilar I, Kocaefe C. Periostin is temporally expressed 
as an extracellular matrix component in skeletal muscle regeneration and differentiation. Gene. 
2014; 553:130–139. [PubMed: 25303869] 
Padial-Molina M, Volk SL, Rios HF. Preliminary insight into the periostin leverage during periodontal 
tissue healing. Journal of clinical periodontology. 2015
Padial-Molina M, Volk SL, Taut AD, Giannobile WV, Rios HF. Periostin is down-regulated during 
periodontal inflammation. Journal of dental research. 2012; 91:1078–1084. [PubMed: 22933606] 
Rangiani A, Jing Y, Ren Y, Yadav S, Taylor R, Feng JQ. Critical roles of periostin in the process of 
orthodontic tooth movement. European journal of orthodontics. 2015
Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH. Differential expression of 
SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. The 
journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 1993; 
41:1467–1477. [PubMed: 8245406] 
Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, Rogers R, Chen Z, Maeda M, 
Kruzynska-Frejtag A, Feng JQ, Conway SJ. periostin null mice exhibit dwarfism, incisor enamel 
defects, and an early-onset periodontal disease-like phenotype. Molecular and cellular biology. 
2005; 25:11131–11144. [PubMed: 16314533] 
Rios HF, Ma D, Xie Y, Giannobile WV, Bonewald LF, Conway SJ, Feng JQ. Periostin is essential for 
the integrity and function of the periodontal ligament during occlusal loading in mice. Journal of 
periodontology. 2008; 79:1480–1490. [PubMed: 18672999] 
Schwanekamp JA, Lorts A, Vagnozzi RJ, Vanhoutte D, Molkentin JD. Deletion of Periostin Protects 
Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling. 
Arteriosclerosis, thrombosis, and vascular biology. 2016; 36:60–68.
Walker et al. Page 15
Cell Tissue Res. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Sharma P, Maffulli N. Biology of tendon injury: healing, modeling and remodeling. Journal of 
musculoskeletal & neuronal interactions. 2006; 6:181–190. [PubMed: 16849830] 
Shih B, Brown JJ, Armstrong DJ, Lindau T, Bayat A. Differential gene expression analysis of 
subcutaneous fat, fascia, and skin overlying a Dupuytren’s disease nodule in comparison to control 
tissue. Hand (N Y). 2009; 4:294–301. [PubMed: 19184239] 
Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, 
Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A. Periostin is essential for cardiac healing after 
acute myocardial infarction. The Journal of experimental medicine. 2008; 205:295–303. [PubMed: 
18208976] 
Shingu T, Bornstein P. Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of 
the mouse thrombospondin 1 gene. The Journal of biological chemistry. 1994; 269:32551–32557. 
[PubMed: 7798257] 
Shiraishi H, Masuoka M, Ohta S, Suzuki S, Arima K, Taniguchi K, Aoki S, Toda S, Yoshimoto T, 
Inagaki N, Conway SJ, Narisawa Y, Izuhara K. Periostin contributes to the pathogenesis of atopic 
dermatitis by inducing TSLP production from keratinocytes. Allergology international : official 
journal of the Japanese Society of Allergology. 2012; 61:563–572. [PubMed: 22918211] 
Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, Li F, Ingram DA, 
Menick D, Field L, Firulli AB, Molkentin JD, Markwald R, Conway SJ. Periostin is required for 
maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. 
Circulation research. 2008; 102:752–760. [PubMed: 18296617] 
Song ZH, Qin ZL. [Expression of periostin and the effect of hydrocortisone on it in human fibroblasts 
of scar]. Beijing da xue xue bao Yi xue ban = Journal of Peking University Health sciences. 2008; 
40:301–305. [PubMed: 18560459] 
Supp DM, Hahn JM, Glaser K, McFarland KL, Boyce ST. Deep and superficial keloid fibroblasts 
contribute differentially to tissue phenotype in a novel in vivo model of keloid scar. Plastic and 
reconstructive surgery. 2012; 129:1259–1271. [PubMed: 22634643] 
Suzuki H, Amizuka N, Kii I, Kawano Y, Nozawa-Inoue K, Suzuki A, Yoshie H, Kudo A, Maeda T. 
Immunohistochemical localization of periostin in tooth and its surrounding tissues in mouse 
mandibles during development. The anatomical record Part A, Discoveries in molecular, cellular, 
and evolutionary biology. 2004; 281:1264–1275.
Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone 
adhesion protein with homology with the insect protein fasciclin I. The Biochemical journal. 1993; 
294(Pt 1):271–278. [PubMed: 8363580] 
Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, 
Wolf CM, Kim JB, Schmitt JP, Molkentin JD, Norris RA, Tager AM, Hoffman SR, Markwald RR, 
Seidman CE, Seidman JG. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated 
by non-myocyte proliferation and requires Tgf-beta. The Journal of clinical investigation. 2010; 
120:3520–3529. [PubMed: 20811150] 
Tkatchenko TV, Moreno-Rodriguez RA, Conway SJ, Molkentin JD, Markwald RR, Tkatchenko AV. 
Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. 
Physiological genomics. 2009; 39:160–168. [PubMed: 19723774] 
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation 
of connective tissue remodelling. Nature reviews Molecular cell biology. 2002; 3:349–363. 
[PubMed: 11988769] 
Ueda K, Yasuda Y, Furuya E, Oba S. Inadequate blood supply persists in keloids. Scandinavian journal 
of plastic and reconstructive surgery and hand surgery / Nordisk plastikkirurgisk forening [and] 
Nordisk klubb for handkirurgi. 2004; 38:267–271.
Walker JT, Kim SSSM, Creber K, Elliott CG, Leask A, Hamilton DW. Cell- matrix interactions 
governing skin repair: matricellular proteins as diverse modulators of cell function. Research and 
Reports in Biochemistry. 2015; 5:73–88.
Wen W, Chau E, Jackson-Boeters L, Elliott C, Daley TD, Hamilton DW. TGF-ss1 and FAK regulate 
periostin expression in PDL fibroblasts. Journal of dental research. 2010; 89:1439–1443. 
[PubMed: 20940356] 
Walker et al. Page 16
Cell Tissue Res. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Wilde J, Yokozeki M, Terai K, Kudo A, Moriyama K. The divergent expression of periostin mRNA in 
the periodontal ligament during experimental tooth movement. Cell and tissue research. 2003; 
312:345–351. [PubMed: 12761672] 
Yamada S, Tauchi T, Awata T, Maeda K, Kajikawa T, Yanagita M, Murakami S. Characterization of a 
novel periodontal ligament-specific periostin isoform. Journal of dental research. 2014; 93:891–
897. [PubMed: 25012810] 
Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z, Aihara M, Takahashi K. Serum 
periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. 
The British journal of dermatology. 2013; 168:717–725. [PubMed: 23110679] 
Yoshiba N, Yoshiba K, Hosoya A, Saito M, Yokoi T, Okiji T, Amizuka N, Ozawa H. Association of 
TIMP-2 with extracellular matrix exposed to mechanical stress and its co-distribution with 
periostin during mouse mandible development. Cell and tissue research. 2007; 330:133–145. 
[PubMed: 17602244] 
Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell research. 2009; 19:128–139. [PubMed: 
19114990] 
Zhang Z, Nie F, Chen X, Qin Z, Kang C, Chen B, Ma J, Pan B, Ma Y. Upregulated periostin promotes 
angiogenesis in keloids through activation of the ERK 1/2 and focal adhesion kinase pathways, as 
well as the upregulated expression of VEGF and angiopoietin1. Molecular medicine reports. 2015; 
11:857–864. [PubMed: 25369801] 
Zhang Z, Nie F, Kang C, Chen B, Qin Z, Ma J, Ma Y, Zhao X. Increased periostin expression affects 
the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic 
conditions. International journal of molecular medicine. 2014; 34:253–261. [PubMed: 24788198] 
Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, Shao Y, Ma W, Yang D, Zhang J. Periostin expression 
is upregulated and associated with myocardial fibrosis in human failing hearts. Journal of 
cardiology. 2014; 63:373–378. [PubMed: 24219836] 
Zhou HM, Wang J, Elliott C, Wen W, Hamilton DW, Conway SJ. Spatiotemporal expression of 
periostin during skin development and incisional wound healing: lessons for human fibrotic scar 
formation. Journal of cell communication and signaling. 2010; 4:99–107. [PubMed: 20531985] 
Walker et al. Page 17
Cell Tissue Res. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Postn message detection in (a) day 5 and (b) day 7 Postn+/+ wounds by in situ hybridization, 
showing Postn expression localizing to the granulation tissue in the wound. The presence of 
Postn message increases significantly from day 5 to day 7. Arrowheads indicate the wound 
borders.
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Figure 2. 
α-smooth muscle actin localization using immunohistochemistry in day 7 (a) Postn+/+ and 
(b) Postn−/− wounds. In Postn+/+, α-SMA is present at the wound border and throughout the 
granulation tissue, but in Postn−/−, it is only present at the wound border, which corresponds 
to the highest area of stress in the wound. Red arrowheads indicate the wound borders.
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Figure 3. 
βig-h3 message detection in day 7 (a) Postn+/+ and (b) Postn−/− wounds by in situ 
hybridization, showing βig-h3 expression associated with the migrating epithelial tongue. 
Red arrowheads indicate the wound borders. Blue arrowheads indicate migrating epithelial 
tongue. White arrows indicate direction of the wound centre.
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Figure 4. 
Schematic representation of periostin expression profile in wound healing and fibrosis. 
Periostin is expressed during the proliferative phase of healing, peaking at day 7, with 
expression continuing, but declining during the remodeling phase. However, in fibrosis, 
periostin expression is maintained.
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